Improving Medication Classification in GLP-1RA Research: Feasibility of a Photo-Review Protocol. (PubMed, Obes Sci Pract) - Sep 24, 2026 - "Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are dominating the type 2 diabetes and obesity intervention landscape, yet their real-world use is increasingly difficult to characterize amid widespread availability of non-FDA-approved, compounded products obtained outside traditional healthcare systems...This study demonstrated that photo review may be a feasible method for improving medication classification in research and offered recommendations for future studies. Additional work is needed to evaluate this protocol in larger and more diverse samples and to refine formulation-specific self-report items."
Journal • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Type 2 Diabetes Mellitus
|
|
Ashley N Gearhardt; Dina H Griauzde; Jacqueline M Katz
|